A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent chemotherapy directly into cancer cells.

A new antibody‑drug conjugate nearly doubles survival and extends overall survival in advanced triple‑negative breast cancer, ...

Targeted drug delivery systems in cancer therapy aim to concentrate therapeutic agents at tumour sites while sparing healthy tissues, thereby enhancing efficacy and minimising systemic toxicity. These ...

Theranostic nanomedicine has emerged as a powerful approach for integrating diagnosis, imaging, targeted therapy, and ...

Experiments in breast cancer models demonstrated a robust gene knockdown, resulting in an increased cancer cell death and a ...

Rising Adoption of Precision Medicine, Expanding ADC Success, and Advanced Targeted Delivery Technologies Are Accelerating ...

Lung cancer remains one of the world's deadliest cancers, yet despite decades of effort to develop new drugs, many fail ...

Targeted drug delivery has long been a cornerstone goal of modern medicine—sending therapies exactly where they’re needed while sparing healthy tissues. Yet creating treatments that can decide when ...

Pune, have developed a biodegradable nanocarrier platform for targeted gene therapy in breast cancer. This strategy uses mesoporous silica nanoparticles to deliver siRNA molecules, effectively ...

RenovoRx, Inc.("RenovoRx" or "the Company") (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath ®, a novel, FDA-cleared ...

Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high therapeutic efficacy. However, many of these compounds possess properties that ...